Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 12;16(4):e254829.
doi: 10.1136/bcr-2023-254829.

Rare manifestations of refractory extrapulmonary sarcoidosis

Affiliations
Case Reports

Rare manifestations of refractory extrapulmonary sarcoidosis

Catarina Teles et al. BMJ Case Rep. .

Abstract

Sarcoidosis is a multisystemic disease, characterised by histopathologic presence of non-necrotising granulomas, primarily affecting the lungs (>90%). We present three cases predominantly characterised by uncommon extrapulmonary manifestations of sarcoidosis, where only one had pulmonary involvement. We describe three female patients, between the second and third decades of life, whose sarcoidosis was a diagnostic challenge due to their atypical extrapulmonary manifestations, from which we highlight: livedo reticularis and painful subcutaneous nodules with uncommon localisation, size and histology, being the first reported case of extensive subcutaneous nodules triggered by intramuscular penicillin; extensive symptomatic and refractory osseous involvement; and dispersed erythema nodosum affecting the entire body surface. All three patients required third-line treatment (antitumour necrosis factor agents) to achieve significant clinical and imagiological improvement. Through this case series, we highlight the importance of considering the rare and atypical presentations of sarcoidosis to avoid diagnostic delays and serious repercussions on the patient's prognosis.

Keywords: Biological agents; Rheumatology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Livedo reticularis on both distal lower extremities.
Figure 2
Figure 2
MRI of the lumbosacral spine with multiple diffuse lesions on vertebral bodies and voluminous L5-S1 disc herniation (white arrow).
Figure 3
Figure 3
18F-fluorodeoxyglucose positron emission tomography/CT with adenopathies and multiple axial and appendicular hypermetabolic areas.
Figure 4
Figure 4
Diffuse erythema nodosum on the left lower limb (A) and abdomen (B).

References

    1. Valeyre D, Prasse A, Nunes H, et al. . Sarcoidosis. Lancet 2014;383:1155–67. 10.1016/S0140-6736(13)60680-7 - DOI - PubMed
    1. Ungprasert P, Carmona EM, Utz JP, et al. . Epidemiology of sarcoidosis 1946-2013: a population-based study. Mayo Clin Proc 2016;91:183–8. 10.1016/j.mayocp.2015.10.024 - DOI - PMC - PubMed
    1. Jeon MH, Kang T, Yoo SH, et al. . The incidence, comorbidity and mortality of sarcoidosis in korea, 2008-2015: a nationwide population-based study. Sarcoidosis Vasc Diffuse Lung Dis 2020;37:24–6. 10.36141/svdld.v37i1.7660 - DOI - PMC - PubMed
    1. Park JE, Kim YS, Kang MJ, et al. . Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003-2015: a nationwide population-based study. Respir Med 2018;144S:S28–34. 10.1016/j.rmed.2018.03.028 - DOI - PubMed
    1. Kowalska M, Niewiadomska E, Zejda JE. Epidemiology of sarcoidosis recorded in 2006-2010 in the silesian voivodeship on the basis of routine medical reporting. Ann Agric Environ Med 2014;21:55–8. - PubMed

Publication types